The aim of this study was to compare two extraction procedures: dynamic headspace-purge and trap (PT) and headspace solid-phase microextraction (HS-SPME) for gas chromatographic determination of benzene, toluene, ethylbenzene, and isomeric xylenes (BTEX) in urine with photoionization (PID) and mass spectrometric (MS) detection, respectively. Both methods showed linearity in the range of interest [(50-2000) ng L
Benzene, toluene, ethylbenzene, m-, p-, and oxylene (BTEX) are ubiquitous pollutants of the indoor and outdoor human environment. Two main sources of these compounds are traffic and tobacco smoking (1) . BTEX are widely used in the manufacture of paints, synthetic rubber, agricultural chemicals and chemical intermediates (2) . BTEX are hazardous carcinogenic and neurotoxic compounds, and are classified as priority pollutants by the US Environmental Protection Agency (EPA), in particular benzene, which the International Agency for Research on Cancer (IARC) classified as a carcinogen in humans (3) .
In non-occupational exposure BTEX were usually analysed in blood (4) (5) (6) (7) or exhaled breath (8) . With development of more sensitive analytical techniques, analysis of those compounds in the urine has become the method of choice due to simplicity and noninvasive sample collection. Since it is not known for BTEX to occur in human urine as a result of normal physiological metabolism, the finding of measurable concentrations of BTEX in the urine should reflect exposure to these aromatic compounds. At the level of environmental exposure, the concentration of BTEX excreted unmodified in the urine is low; the proportion is usually in the order of 1 % or less of the absorbed dose (9) , so the quantification of BTEX in the urine of general population has become possible thanks to the development of the very sensitive analytical techniques which permit determination at levels as low as ng L -1 (1, 5, 10) . Several instrumental variations are described for the low level BTEX determinations in the urine. These include different sampling techniques such as dynamic headspace (thermal desorption, TD and purge and trap, PT) (10-12) and headspace solid-phase microextraction (HS-SPME) (1, 5, 13) followed by gas chromatographic separation and flame ionization (10) (11) (12) and/or mass spectrometric (1, 5, 10, 13) detection.
Headspace sampling (HS) is suitable for BTEX determination in the urine because of their volatility. This technique can be performed in a static or a dynamic way. Static headspace involves sampling gas phase aliquot over the sample using a gas tight syringe after equilibration in a sealed vial. Dynamic headspace enriches volatiles caught by a cold trap or an inert support (e.g. Tenax), by stripping them continuously with an inert gas flow through the sample. Headspace solid-phase microextraction, developed by Zhang and Pawliszyn (14) to evaluate volatile compounds from water, is an advancement in the static headspace approach. With this sampling technique, volatile substances from the headspace of sample are adsorbed and concentrated onto a fusedsilica fibre coated with a thin layer of a selective coating [usually 100 µm of polydimethylsiloxane (PDMS) for BTEX].
The aim of this study was to compare BTEX extraction using PT and HS-SPME, and to find out which of the two procedures could be recommended for routine BTEX analysis in the urine. HS-SPME was applied for the quantitative analysis of BTEX in the urine samples collected from 20 healthy adults without any known occupational BTEX exposure.
MATERIALS, METHODS, AND SUBJECTS

Materials
Benzene, toluene, ethylbenzene, o-, m-, p-xylene, and methanol were analytical-grade-purity products of Merck (Darmstadt, Germany). Standard reference material for BTEX with 2000 µg of each compound per mL of methanol was purchased from Supelco (Bellefonte, USA) and an aqueous emulsion (30 %) of Antifoam A concentrate from Sigma Chemical (St. Louis, USA). Headspace vials (6 mL) with PTFE septum and holed aluminium caps, hand crimper, and decapper were obtained from Varian (Harbor City, USA).
Standard Preparation
Stock solutions were prepared by two serial dilution steps in methanol. Stock solution A was prepared by spiking 3 µL of each analyte to 10 mL of methanol. Stock solution B was prepared by dilution of 150 µL of stock A to 10 mL of methanol for the PT method, and 50 µL of stock A to 10 mL of methanol for HS-SPME. Working standards were prepared by spiking known amounts of stock B into deionized water, purified under a stream of dry nitrogen at 50 °C for 4 hours. One hundred µL of working standards were added to 9.9 mL of blank urine for the PT method and to 0.9 mL of blank urine for the HS-SPME method. The stock solutions were kept at -20 °C, and working standards were freshly prepared every day.
The urine used for standard preparation was collected from non-smoking, occupationally nonexposed donors. Pooled urine was analysed before spiking, and the calibration curves were corrected for its BTEX content.
The samples prepared using the PT procedure were analysed by gas chromatography (GC) with photoionization detection (PID) and those prepared using the HS-SPME procedure by gas chromatographymass spectrometry (GC-MS).
PT-GC-PID procedure
The purge vessel containing 10 mL of urine and (0.5-1.0) mg of lyophilisated antifoam A was flushed with helium for 10 minutes at room temperature (21 °C) to purge volatile components. These components were transferred by carrier gas (helium) to a fused silica trap, and cooled to -100 °C by liquid nitrogen. After the refocusing of components, the cold trap was flash-heated (200 °C for 1 min), and the components were injected onto the Rtx-624 (Restek, Bellefonte, USA) capillary column (60 m x 0.32 mm I.D., 1.8 µm film thickness) where they were separated. We used a Varian 3800 gas chromatograph, equipped with a CP-4010 Purge and Trap Injector (PTI), Thermal Desorption Cold Trap Injector (TCT) (Chrompack, Middleburg, Netherlands), and photoionization detector (Varian, Walnut Creek, CA, USA). After injection, the column temperature was programmed to maintain at 70 °C for the first 10 min, then rise to 150 °C at the rate of 6 °C min -1 and maintain this temperature for 4 min, then again rise to 200 °C at the rate of 30 °C min -1 and maintain this temperature for another 3 min. The flow rate of the carrier gas (helium) was 1 mL min -1 . The make-up gas (nitrogen) flow was 29 mL min -1 . The detector temperature was 230 °C. This method has been described earlier (12) .
HS-SPME-GC-MS procedure
Clear glass vials (6 mL) with a stir bar were filled with 1 mL of urine, sealed with PTFE septum and holed aluminium caps. The vials were equilibrated at room temperature (21 °C) for 30 min. Fused silica fibre 10 mm long, coated with a 100 µm thick PDMS film was used (Supelco, Bellefonte, USA). The fibre was exposed to the headspace above the sample for 15 min at room temperature (21 °C). During the extraction, the urine sample was stirred (300 rpm). After the extraction, the fibre was pulled in the stainless steel needle and inserted into the SPI injector (septum-equipped programmable injector). Analytes were thermally desorbed from the SPME fibre at 200 °C for 3 min and analysed using a Varian 3400 CX gas chromatograph with Saturn ion trap mass spectrometer operating in the electron impact (EI) mode. The components were injected onto the Rtx-5 (Restek, Bellefonte, USA) capillary column (30 m x 0.25 mm I.D., 0.25 µm film thickness). The oven temperature was kept at 35 °C for 2 min, and then the temperature was raised to 90 °C at 5 °C min -1 . Lateeluating compounds were removed by increasing the temperature to 300 °C at 50 °C min -1 . The flow rate of helium carrier gas was 1 mL min -1 . The delay time was 2 min. Monitored ions were m/z 78 (benzene) and 91 (toluene, ethylbenzene, and xylenes).
Analytical Validation
Calibration curves were obtained by analysing urine spiked with (50-2000) ng L -1 of BTEX. Least-squares linear regression analysis was used to estimate the slopes (b) and intercepts (a) of calibration curves y=bx+a, where y is the chromatographic area of the analyte, and x is the concentration of the analyte in urine (ng L -1 ). The detection limit (DL) for each analysed aromatic hydrocarbon was calculated according to the equation:
where SE a is the standard error of the intercept (15) .
The accuracy of the methods was obtained from six replicate analyses of urine samples spiked with 100 ng L -1 and 600 ng L -1 of BTEX using the reference standard.
The precision of the methods was expressed as relative standard deviation, RSD %. The repeatability was also estimated from six replicate analyses of urine samples spiked with 100 ng L -1 and 600 ng L -1 of BTEX.
Subjects and urine sampling
BTEX were determined in 20 urine samples from healthy adults (10 non-smokers and 10 smokers) without any known occupational BTEX exposure. Median age of the subjects was 33 years, and 60 % were women.
The first urine samples were collected in the morning in clean 80-mL bottles, filled completely to avoid losses to the headspace and analysed on the day of collection using the HS-SPME-GC-MS procedure described above.
This study has been approved by the ethical committee of the Institute for Medical Research and Occupational Health, and has been performed according to the Declaration of Helsinki.
Statistics
We performed all statistical analyses using Statistica for Windows, release 5.5 (StatSoft Inc., Tulsa, Oklahoma, USA). The results within groups are presented as median and range, and the significance of the difference between groups was calculated by using the Mann-Whitney U test. Undetectable concentrations were set at 0.5xDL. Figure 1 shows PT-GC-PID chromatogram of blank urine spiked with 800 ng L -1 of BTEX. Total ion current and single ion chromatograms obtained by HS-SPME-GC-MS, shown in Figure 2 , correspond to the blank urine spiked with the same concentration of BTEX (800 ng L -1 ). Both described methods allowed separation and sensitive determination of BTEX in urine. The obtained peaks were sharp, narrow, and well separated from impurity peaks because of the pre-concentration step. Under the used experimental conditions, it was not possible to resolve m-and p-xylene and consequently they were calculated together. As the photoionization detector is not sensitive enough for the HS-SPME analysis of BTEX in the urine at the concentration level resulting from environmental exposure, a mass spectrometer was used as a detector for HS-SPME analysis. Table 1 summarises the calculated DL, accuracy, and repeatability for the determination of BTEX in the urine by both methods. Calibration curves were linear over the concentration range (50-2000) ng L -1 with correlation coefficients >0.998 for both methods. The calculated DL ranged between 15 ng L -1 (for toluene) and 35 ng L -1 (for ethylbenzene) for PT-GC-PID, and between 39 ng L -1 (for toluene) and 50 ng L -1 (for benzene) for HS-SPME-GC-MS. According to our results, PT-GC-PID had 1.4 to 2 times lower DLs than HS-SPME, except for ethylbenzene, where the same DLs were calculated for both methods. We obtained lower DLs for PT-GC-PID than Fustinoni et al. (11) who used the same extraction method. Andreoli et al. (5) and Fustinoni et al. (1) obtained lower DLs than we did, using the same extraction method (HS-SPME), but our calculated DLs were significantly lower than those calculated by Krämer-Alkade et al. (16) .
RESULTS AND DISCUSSION
Accuracy for both methods was similar and greater than those previously reported (10, 11, 16) . Relative standard deviations at the two BTEX concentrations were also similar: RSD≤11 % and ≤10 % for HS-SPME-GC-MS and PT-GC-PID, respectively. They are comparable with repeatability studies reported by The use of an antifoam agent is critical in the PT analysis to prevent urine from foaming. We used Antifoam A and found that obligatory purification by lyophilisation after heating antifoam agent under a stream of dry nitrogen is absolutely needed, which makes PT analysis impractical. Besides, the PT method has more drawbacks: it requires complex and expensive instrumentation, it is time-consuming, and not suitable for routine analyses.
The sensitivity of HS-SPME-GC-MS was good enough for BTEX determination in the urine samples collected from the general population. Table 2 summarises mass concentrations of BTEX in the urine of 10 non-smokers and 10 smokers. Earlier findings showed no need for creatinine correction of BTEX in the urine (17) . BTEX were measurable in all samples, except for benzene in one sample, and oxylene in four samples. Toluene had the highest and o-xylene the lowest urinary concentration among the solvents studied. Smokers had significantly higher urinary BTEX concentrations than non-smokers. Our results were similar to those reported by others (5, 7, 10, 13) . The exception in our study was toluene, Our results were, however, higher than those reported in our previous study (17) , probably due to a difference in sampling time; in this study we collected samples in the winter, and in the earlier study in the summer when lower concentrations of BTEX in air (affecting BTEX concentration in urine) were found because of reduced heating and enhanced photochemical degradation during the summer. In addition, general population spend more time inside the house during the winter and it is well known that indoor air concentrations of BTEX frequently exceed those outdoors (6).
CONCLUSIONS
Both methods showed very good repeatability, linearity and accuracy within the range studied. In addition, both methods are solvent-free, and do not require sample preparation. Extraction and preconcentration of BTEX are carried out in a single step, and detection limits in the range of ng L -1 are easily achieved. The cost of the PT system is relatively high, and handling during analysis is much more complicated than for HS-SPME. Furthermore, retention times may vary because of pressure changes within the PT system. The main advantage of HS-SPME is that it is simple to use, and needs less complex instrumentation than PT, but it also requires immediate GC analysis of the volatile compounds. The shorter time required for the whole analytical process (32 min versus 45 min for PT), small sample volume (1 mL versus 10 mL for PT), and simple handling could be good reasons to recommend HS-SPME for routine analysis of BTEX in urine. 
